类固醇诱导的血栓形成:使用FAERS数据库进行全面分析
Ayame Watanabe1, Yoshihiro Uesawa1
1Department of Medical Molecular Informatics, Meiji Pharmaceutical University, Tokyo 204-8588, Japan.
Pharmaceuticals (Basel, Switzerland)
|October 29, 2025
概括
类固醇药物,特别是性激素,增加了血栓形成的风险,包括静脉血栓形成和大血管封闭. 了解这些风险有助于为高风险患者选择更安全的类固醇药物.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血栓形成研究研究
- 药品安全 药品安全
背景情况:
- 类固醇药物可以诱导血栓形成,这是一种具有严重后果的疾病,如心脏病发作和中风.
- 目前对类固醇诱导的血栓形成机制和不同风险的知识有限.
研究的目的:
- 调查各种类固醇药物类与血栓形成风险之间的关系.
- 为了确定特定的类固醇类型,更容易引起血栓事件.
主要方法:
- 使用美国食品和药物管理局的不良事件报告系统 (2004-2024年).
- 提取的人口,药物和不良事件数据.
- 通过生理功能,受体特异性和解剖治疗化学品分类来表征类固醇.
主要成果:
- 性激素 (雄激素,孕激素,雌激素) 显示出发生血栓事件的高潜力.
- 通过统计分析,性激素制剂与静脉血栓形成风险增加有关.
- 心血管药物和矿物质皮质类药物与大血管封闭有关.
结论:
- 这些发现突出了与明显的血栓形成风险相关的特定类型的类固醇药物.
- 这些信息可以指导临床决策,在脆弱患者中选择更安全的类固醇疗法.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis III: Interprofessional Care
276
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
276
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K

